metsera glp-1 Metsera's Receptor Agonist MET-097i Metsera GLP-1 data slice reveals

Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents

Furthermore, its short half-life of less than 3 h (Min et al., 2025) necessitates twice-daily injections to maintain efficacy, which can be a limiting factor for long-term patient adherence

In the 2023 New England Journal of Medicine trial, the retatrutide treatment groups showed not only gastrointestinal abnormalities but also a dose-dependent increase in heart rate

Bottom Line Calibrate is not for those looking for a miracle weight-loss solution

Under certain circumstances, health insurance companies may cover the cost of a prescription drug that they normally dont cover